Angioplasty Balloons Market Size, Share, Trends, Growth Outlook

Angioplasty Balloons Market is estimated to increase at a growth rate of 4.5% CAGR over the forecast period from 2024 to 2030.

 

The Angioplasty Balloons Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Normal Balloons, Drug Eluting Balloons, Cutting Balloons, Scoring Balloons), By Application (Peripheral, Coronary), By End-User (ASCs, Hospitals, Cath Labs).

 

An Introduction to Angioplasty Balloons Market in 2024

The Angioplasty Balloons market in 2024 encompasses a range of specialized medical devices used in percutaneous transluminal angioplasty procedures to treat coronary and peripheral artery disease. These balloons feature inflatable catheter systems equipped with semi-compliant or non-compliant balloons, which are navigated to the site of arterial stenosis and inflated to dilate narrowed blood vessels, restore blood flow, and improve myocardial perfusion or limb circulation. With ongoing advancements in balloon design, coatings, and delivery systems, angioplasty balloons offer clinicians enhanced precision, flexibility, and deliverability, enabling optimal lesion treatment and minimizing the risk of procedural complications. As endovascular interventions continue to gain prominence as a minimally invasive alternative to surgical revascularization, the angioplasty balloons market remains a critical component of interventional cardiology and vascular surgery, driving innovation and improving patient outcomes.

 

 

Angioplasty Balloons Market Trend: Shift Towards Drug-Coated Angioplasty Balloons

A prominent trend in the Angioplasty Balloons market is the increasing adoption of drug-coated angioplasty balloons for the treatment of coronary and peripheral artery disease. Drug-coated balloons (DCBs) deliver antiproliferative agents directly to the vessel wall during angioplasty, inhibiting restenosis and reducing the need for additional interventions such as stenting. As clinical evidence supporting the efficacy and safety of DCBs continues to accumulate, there is a growing preference for these devices over conventional plain balloons. This trend reflects the industry's focus on improving long-term outcomes and reducing the incidence of restenosis in patients undergoing angioplasty procedures.

Angioplasty Balloons Market Driver: Rising Prevalence of Cardiovascular Diseases and Peripheral Artery Disease

A key driver in the Angioplasty Balloons market is the rising prevalence of cardiovascular diseases (CVDs) and peripheral artery disease (PAD) globally. Factors such as sedentary lifestyles, unhealthy diets, aging populations, and increasing prevalence of diabetes contribute to the growing burden of CVDs and PAD. Angioplasty balloons play a vital role in the management of these conditions by restoring blood flow to occluded or stenotic arteries, alleviating symptoms, and reducing the risk of cardiovascular events. As the incidence of CVDs and PAD continues to rise, driven by demographic shifts and lifestyle factors, the demand for angioplasty balloons is expected to escalate, driving market growth.

Angioplasty Balloons Market Opportunity: Development of Next-Generation Drug-Eluting Technologies

One potential opportunity in the Angioplasty Balloons market lies in the development of next-generation drug-eluting technologies that offer improved drug delivery and therapeutic efficacy. Manufacturers can focus on enhancing the drug-coating formulations, balloon materials, and delivery mechanisms to optimize drug release kinetics, increase drug bioavailability, and ensure uniform drug distribution across the treated vessel segment. Additionally, innovating to develop balloons with integrated imaging or sensing capabilities, such as optical coherence tomography (OCT) or intravascular ultrasound (IVUS), presents an opportunity to improve procedural guidance and optimize treatment outcomes. By investing in research and development to advance drug-eluting balloon technologies, manufacturers can address unmet clinical needs, expand their product offerings, and gain a competitive edge in the dynamic angioplasty market landscape.

 

Angioplasty Balloons Market Segmentation

By Type

Normal Balloons

Drug Eluting Balloons

Cutting Balloons

Scoring Balloons

 

By Application

Peripheral

Coronary

 

By End-user

ASCs

Hospitals

Cath Labs

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Angioplasty Balloons Market Companies

Abbott

B. Braun Melsungen AG

BIOTRONIK

Boston Scientific Corp

C. R. Bard Inc

Cardinal Health

Cook

ENDOCOR GmbH

Johnson & Johnson Services Inc

Medtronic

Spectranetics

Terumo Medical Corp

*- List Not Exhaustive

 

Reasons to Buy the Angioplasty Balloons Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Angioplasty Balloons Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Angioplasty Balloons Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Angioplasty Balloons Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Angioplasty Balloons Market Size Outlook, $ Million, 2021 to 2030

3.2 Angioplasty Balloons Market Outlook by Type, $ Million, 2021 to 2030

3.3 Angioplasty Balloons Market Outlook by Product, $ Million, 2021 to 2030

3.4 Angioplasty Balloons Market Outlook by Application, $ Million, 2021 to 2030

3.5 Angioplasty Balloons Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Angioplasty Balloons Market Industry

4.2 Key Market Trends in Angioplasty Balloons Market Industry

4.3 Potential Opportunities in Angioplasty Balloons Market Industry

4.4 Key Challenges in Angioplasty Balloons Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Angioplasty Balloons Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Angioplasty Balloons Market Outlook By Segments

7.1 Angioplasty Balloons Market Outlook by Segments

By Type

Normal Balloons

Drug Eluting Balloons

Cutting Balloons

Scoring Balloons

By Application

Peripheral

Coronary

By End-user

ASCs

Hospitals

Cath Labs

 

8 North America Angioplasty Balloons Market Analysis And Outlook To 2030

8.1 Introduction to North America Angioplasty Balloons Markets in 2024

8.2 North America Angioplasty Balloons Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Angioplasty Balloons Market size Outlook by Segments, 2021-2030

By Type

Normal Balloons

Drug Eluting Balloons

Cutting Balloons

Scoring Balloons

By Application

Peripheral

Coronary

By End-user

ASCs

Hospitals

Cath Labs

 

9 Europe Angioplasty Balloons Market Analysis And Outlook To 2030

9.1 Introduction to Europe Angioplasty Balloons Markets in 2024

9.2 Europe Angioplasty Balloons Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Angioplasty Balloons Market Size Outlook By Segments, 2021-2030

By Type

Normal Balloons

Drug Eluting Balloons

Cutting Balloons

Scoring Balloons

By Application

Peripheral

Coronary

By End-user

ASCs

Hospitals

Cath Labs

 

10 Asia Pacific Angioplasty Balloons Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Angioplasty Balloons Markets in 2024

10.2 Asia Pacific Angioplasty Balloons Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Angioplasty Balloons Market size Outlook by Segments, 2021-2030

By Type

Normal Balloons

Drug Eluting Balloons

Cutting Balloons

Scoring Balloons

By Application

Peripheral

Coronary

By End-user

ASCs

Hospitals

Cath Labs

 

11 South America Angioplasty Balloons Market Analysis And Outlook To 2030

11.1 Introduction to South America Angioplasty Balloons Markets in 2024

11.2 South America Angioplasty Balloons Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Angioplasty Balloons Market size Outlook by Segments, 2021-2030

By Type

Normal Balloons

Drug Eluting Balloons

Cutting Balloons

Scoring Balloons

By Application

Peripheral

Coronary

By End-user

ASCs

Hospitals

Cath Labs

 

12 Middle East And Africa Angioplasty Balloons Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Angioplasty Balloons Markets in 2024

12.2 Middle East and Africa Angioplasty Balloons Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Angioplasty Balloons Market size Outlook by Segments, 2021-2030

By Type

Normal Balloons

Drug Eluting Balloons

Cutting Balloons

Scoring Balloons

By Application

Peripheral

Coronary

By End-user

ASCs

Hospitals

Cath Labs

 

13 Company Profiles

13.1 Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Abbott

B. Braun Melsungen AG

BIOTRONIK

Boston Scientific Corp

C. R. Bard Inc

Cardinal Health

Cook

ENDOCOR GmbH

Johnson & Johnson Services Inc

Medtronic

Spectranetics

Terumo Medical Corp

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Angioplasty Balloons Market Segmentation

By Type

Normal Balloons

Drug Eluting Balloons

Cutting Balloons

Scoring Balloons

 

By Application

Peripheral

Coronary

 

By End-user

ASCs

Hospitals

Cath Labs

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)